Bollineni Eye Hospital And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 22 Year, 4 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 1.08 Cr
as on 23-12-2024
- Revenue %
(FY 2018)
- Profit 64.53%
(FY 2018)
- Ebitda -395.38%
(FY 2018)
- Net Worth -0.10%
(FY 2018)
- Total Assets 100.56%
(FY 2018)
About Bollineni Eye Hospital And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.08 Cr.
Seshama Nagam, Saimurali Nagam, and Bhaskar Katamreddy serve as directors at the Company.
- CIN/LLPIN
U85110AP2002PTC039497
- Company No.
039497
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2002
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Nellore, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bollineni Eye Hospital And Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saimurali Nagam  | Managing Director | 22-Aug-2002 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Seshama Nagam | Director | 22-Aug-2002 | Current |
| Bhaskar Katamreddy | Additional Director | 18-Jun-2024 | Current |
Financial Performance of Bollineni Eye Hospital And Research Centre.
Bollineni Eye Hospital And Research Centre Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 64.53% increase in profit. The company's net worth dipped by a decrease of 0.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bollineni Eye Hospital And Research Centre?
In 2018, Bollineni Eye Hospital And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Ltd Creation Date: 20 Mar 2003 | ₹1.08 Cr | Open |
How Many Employees Work at Bollineni Eye Hospital And Research Centre?
Unlock and access historical data on people associated with Bollineni Eye Hospital And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bollineni Eye Hospital And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bollineni Eye Hospital And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
